💊 Salmeterol and fluticasone (Fluticasone Propionate And Salmeterol Diskus)
A dry-powder inhaler (DISKUS) that combines a corticosteroid with a long-acting bronchodilator. It is used twice daily to treat asthma and as maintenance treatment of airflow obstruction in COPD. It is not intended to relieve sudden, acute breathing difficulty.
In Arabic: فلوتيكازون بروبيونات وسالميتيرول✅ What it is used for
- Twice-daily treatment of asthma in patients aged 4 years and older
- Maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema
- Reducing COPD exacerbations in patients with a history of exacerbations
- For asthma patients not adequately controlled on a long-term control medication such as an inhaled corticosteroid, or whose disease warrants starting both an ICS and a LABA
- NOT indicated for relief of acute bronchospasm
🧪 Active ingredient
The active ingredients are fluticasone propionate (a synthetic anti-inflammatory corticosteroid) and salmeterol xinafoate (a selective long-acting beta2-agonist bronchodilator).
🌿 Benefits
- Helps control asthma symptoms when used regularly
- Improves airflow obstruction in COPD
- Reduces COPD exacerbations in patients with a history of exacerbations
- Improvement in asthma may begin within 30 minutes, with maximum benefit after 1 week or longer
📝 How to use
- For oral inhalation only: 1 inhalation twice daily, approximately 12 hours apart
- The dose and strength are set by your doctor or pharmacist based on your condition; do not change them yourself
- After each inhalation, rinse your mouth with water without swallowing to help reduce the risk of oral thrush (candidiasis)
- Do not use more than 1 inhalation twice daily
- Do not use any additional LABA-containing medicine with this product
- If asthma symptoms arise between doses, use a short-acting inhaled beta2-agonist for immediate relief as directed by your doctor
- Asthma control may improve within 30 minutes, though maximum benefit may take 1 week or longer
💊 Dosage forms
- Inhalation powder in an inhaler (DISKUS) containing a foil blister strip
- Strengths: fluticasone propionate 100, 250, or 500 mcg with salmeterol 50 mcg per blister
- Supplied in the provided label as 1 inhaler in a carton (60 doses)
⚠️ Common side effects
- Upper respiratory tract infection or inflammation
- Pharyngitis (sore throat)
- Hoarseness/dysphonia
- Oral candidiasis (thrush)
- Bronchitis and cough
- Headache
- Nausea and vomiting
- In COPD: pneumonia, throat irritation, viral respiratory infections, musculoskeletal pain
🚨 Serious — seek medical help
- Serious asthma-related events (hospitalization, intubation, death) with LABA monotherapy
- Pneumonia in patients with COPD
- Paradoxical bronchospasm (worsened wheezing after inhalation), requiring discontinuation
- Severe hypersensitivity reactions
- Hypercorticism and adrenal suppression
- Reduced bone mineral density
- Glaucoma and cataracts
- Cardiovascular and central nervous system effects
- Hypokalemia and hyperglycemia
- Reduced growth in children
- Worsening of existing infections (e.g., tuberculosis; fungal, bacterial, viral, or parasitic infections)
⛔ Do not use if
- Primary treatment of status asthmaticus or other acute episodes of asthma or COPD requiring intensive measures
- Severe hypersensitivity to milk proteins
- Demonstrated hypersensitivity to fluticasone propionate, salmeterol, or any excipient (the product contains lactose, which contains milk proteins)
❗ Warnings & precautions
- Do not start in acutely deteriorating asthma or COPD, and do not use to treat acute symptoms
- Do not use with another LABA-containing medicine because of overdose risk
- Monitor for signs and symptoms of pneumonia in COPD patients
- Use with caution in patients with infections (tuberculosis, fungal, bacterial, viral, parasitic, ocular herpes simplex); chickenpox or measles may take a more serious or fatal course in susceptible patients
- Risk of impaired adrenal function when transferring from systemic corticosteroids; taper slowly
- If hypercorticism or adrenal suppression occurs, discontinue slowly
- Use with caution in cardiovascular or central nervous system disorders
- Assess bone mineral density initially and periodically
- Monitor growth in pediatric patients
- Consider ophthalmology referral for ocular symptoms or long-term use
- Be alert to eosinophilic conditions, hypokalemia, and hyperglycemia
- Use with caution in convulsive disorders, thyrotoxicosis, and diabetes mellitus
- Monitor patients with hepatic impairment for signs of increased drug exposure
🔄 Drug interactions
- Strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, clarithromycin, itraconazole): use not recommended; may increase systemic corticosteroid and cardiovascular effects
- Monoamine oxidase inhibitors and tricyclic antidepressants: use with extreme caution; may potentiate salmeterol's effect on the vascular system
- Beta-blockers: use with caution; may block bronchodilatory effects and produce severe bronchospasm
- Diuretics (non-potassium-sparing): use with caution; ECG changes and/or hypokalemia may worsen with beta-agonists
- The product has been used with short-acting beta2-agonists, methylxanthines, and intranasal corticosteroids without adverse drug reactions; no formal interaction trials have been performed
- Tell your doctor or pharmacist about all medicines you take
🤰 Pregnancy
There are insufficient data on use of this product or its components in pregnant women. Animal studies showed fetal effects at maternally toxic doses. Poorly controlled asthma increases pregnancy risks (e.g., pre-eclampsia, prematurity, low birth weight), so discuss benefits and risks with your doctor and keep asthma well controlled.
🍼 Breastfeeding
The label text provided contains no information on breastfeeding; consult your doctor before use while breastfeeding.
🧒 Children
Used for asthma in patients aged 4 years and older; for ages 4 to 11 the dose is the 100/50 mcg strength twice daily. Safety and effectiveness in children with asthma younger than 4 years have not been established. Inhaled corticosteroids may reduce growth velocity, so growth should be monitored. COPD is not an indication in children.
👴 Older adults
No dosage adjustment is warranted based on age. In COPD patients aged 65 and older, serious adverse events and the excess risk of pneumonia were higher. Special caution is advised in older patients with cardiovascular disease that could be adversely affected by beta2-agonists.
🌡️ Storage
Storage conditions are not detailed in the label text provided. Follow the instructions on the package or ask your pharmacist.
⏰ Missed dose
The label text provided gives no guidance on missed doses. Do not double a dose; follow your doctor's or pharmacist's instructions.
🆘 Overdose
No human overdosage data have been reported for this product. Excess salmeterol may cause signs of beta-adrenergic overstimulation (tremor, palpitations, tachycardia, high or low blood pressure, headache, nausea, dizziness, insomnia, seizures, arrhythmias, hyperglycemia, hypokalemia), and chronic excess corticosteroid may cause hypercorticism. Treatment consists of discontinuing the drug with symptomatic and supportive therapy and cardiac monitoring. Seek medical help immediately.
💰 Price & brands in your area
Local prices are currently available for Palestine; more countries are coming. Ask your pharmacist for local price and alternatives.
📍 Find the nearest pharmacy
Your location is used only in your browser to show nearby pharmacies — we don't store it.
Open in Google Maps👨⚕️ For healthcare professionals
Mechanism of action
Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity and high binding affinity for the human glucocorticoid receptor. Salmeterol is a selective long-acting beta2-adrenoceptor agonist (at least 50 times more selective for beta2-adrenoceptors than albuterol in vitro). The two components act through different mechanisms on clinical, physiologic, and inflammatory indices.
Labeled dosing
1 inhalation twice daily, approximately 12 hours apart, by oral inhalation only. Asthma, age 12 and older: 100/50, 250/50, or 500/50 mcg twice daily, starting strength based on severity (maximum 500/50 mcg twice daily). Asthma, ages 4 to 11: 100/50 mcg twice daily. COPD: 250/50 mcg twice daily (the only approved dosage; no efficacy advantage shown for 500/50). Final dose is determined by the prescriber.
- Rinse mouth with water after inhalation to reduce oropharyngeal candidiasis risk
- More than 1 inhalation twice daily is not recommended due to higher likelihood of salmeterol adverse effects
- Not for acute bronchospasm; a short-acting beta2-agonist should be used for symptoms between doses
- If inadequate response after 2 weeks, consider a higher strength or reevaluate the regimen
- Avoid additional LABA and strong CYP3A4 inhibitors
- Monitor growth in children, bone mineral density, eyes, and pneumonia in COPD
🎓 Key points for students
- Combines an inhaled corticosteroid (ICS) with a long-acting beta2-agonist (LABA)
- Both components are CYP3A4 substrates, so strong inhibitors are avoided
- LABA monotherapy increases risk of serious asthma-related events, hence the ICS combination
- 250/50 mcg twice daily is the only approved COPD dosage
- Increased pneumonia risk in COPD patients
- The lactose excipient contains milk proteins, making severe milk-protein hypersensitivity a contraindication
EME runs your whole clinic: appointments with WhatsApp reminders, patient files, finance & inventory, a patient portal and a members-price medical store — with your data isolated and protected.
Try EME free How we protect your data❓ FAQ
Can this medicine be used to relieve a sudden asthma attack?
No. It is not indicated for relief of acute bronchospasm. Use the short-acting reliever inhaler prescribed by your doctor for symptoms between doses.
Why should I rinse my mouth after inhaling?
To help reduce the risk of oral thrush (fungal infection of the mouth and throat) from the inhaled corticosteroid. Rinse with water without swallowing.
How often is it used each day?
One inhalation twice daily, about 12 hours apart, with the dose set by your doctor. Do not increase the number of inhalations.
Can I use it with another LABA medicine?
No. Additional LABA should not be used for any reason because of the risk of overdose.
How soon does it work?
Asthma control may improve within 30 minutes of starting treatment, but maximum benefit may take a week or longer and varies between individuals.
Is it suitable for children?
It is used for asthma in patients aged 4 and older, with the 100/50 mcg strength for ages 4 to 11, and growth should be monitored. Safety and effectiveness under age 4 have not been established.
⚕️ For education only — not a substitute for advice from your doctor or pharmacist. Do not start or stop any medicine without advice. Source: official FDA drug label via openFDA (2026-10), simplified. Updated: 2026-11-16.